SCA
GEVA

SAC Capital Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

SAC Capital Advisors’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3,187
Closed -$202K – 2037
2013
Q3 		$202K Sell
3,187
-46,013
-94% -$2.92M ﹤0.01% 1523
2013
Q2 		$2.07M Buy
+49,200
New +$2.07M 0.01% 673